DCF ScreenerData as of Oct 10, 2026, 1:06 AM UTC
← Screener

AMGN Amgen Inc.

Healthcare

Price
$402.60
Intrinsic value
$80.45
Buy price
$64.36
Discount
-400.4%
Overvalued

Live signals (1)

Daily bars as of Oct 8, 2026
  • DCDowntrend ContinuationBearish ↓

    A strong bearish bar rejecting a falling 20/50-SMA stack - the downtrend resuming after a bounce into the moving averages.

    Fired Oct 2, 20264 daily bars ago32.9% win rate · 0.89x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)0.81%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$12,478,000,000.00
Total debt
$57,303,998,464.00
Cash & STI
$13,989,000,192.00
Shares out.
544,000,000
Overvalued
Intrinsic value$80.47
Buy price (with MOS)$64.38
Current price$402.60
Discount to intrinsic value-400.3%

7-step quality scorecard

ROE quality
HIGH_DISTORTED
Average ROE
111.4%
Current ROE
89.1%
Minimum ROE
69.6%
Debt quality
LEVERAGED
Debt / Equity
6.62x
Moat proxy
WEAK_PROXY
Cash-flow reliability
OK
Operating CF / Net income
1.43x

Technical chart

Confluence: WEAK (1/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source
yfinance
Growth (g1) source
min(cfCAGR,revenueCAGR)
Valuation model
DCF_OCF
Debt as % of DCF PV
65.8%
Public economic interest
100.0%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.